Hank serves as entrepreneur and advisory board member in the digital health community. As COO of Luminopia, he is working on the world’s first digital therapeutic to treat neuro-visual disorders. Hank’s startup highlights include advanced analytics for cell therapy (acquired), Flagship and Google-backed biotech (IPO), and medical diagnoses and prescriptions through machine learning (seed).
Previously at Biogen, Hank was responsible for digital strategy and R&D IT – where he worked on digital biomarkers; created the data science and health tech talent program; and earned industry awards in scientific computing and digital innovation.
Hank received his training from the University of California, Berkeley (electrical engineering and computer science), Johns Hopkins University (biotech) and MIT Sloan (business). He is a co-author of scientific publications and patents.
At the Wyss Institute, Hank is a member of the Wyss Mentor Hive who specializes in digital health, data science, FDA regulation, exit strategy, and human capital.
The Wyss Mentor Hive is a mentoring program that invites investors and business professionals with significant early stage translational experience, clinical and regulatory experts in driving therapeutic and device development, and serial entrepreneurs with a track record of success to work closely with Wyss entrepreneur teams on startup formation and technology commercialization. Mentors provide feedback to founders and entrepreneurs, while also demonstrating commitment and leadership in the Wyss innovation community.